Drug Development and Industrial Pharmacy is a prestigious journal published by Taylor & Francis Ltd, focusing on the critical field of pharmaceutical sciences. With an ISSN of 0363-9045 and an E-ISSN of 1520-5762, the journal has been an essential resource for researchers and professionals since its inception in 1974. It occupies a crucial niche within Drug Discovery, Organic Chemistry, and Pharmaceutical Science, currently ranked in the second and third quartiles, reflecting its solid contribution to the field. The journal encompasses a wide array of topics, including drug development processes, formulation, and industrial manufacturing alongside cutting-edge research in pharmacology and toxicology. With a commendable Scopus ranking demonstrating high relevance—ranked #44 in Pharmaceutical Science—it serves as a vital forum for academia and industry to share innovative findings and methodologies. While it does not offer open access, the journal remains an invaluable resource for those seeking to advance their knowledge and enhance their research in pharmaceutical development.

Pharmacy & Pharmacology-Farmatsiya i Farmakologiya is a distinguished journal published by the Pyatigorskii Mediko-Farmatsevticheskii Inst in the Russian Federation, dedicated to advancing research in the fields of pharmacy and pharmacology. Since its transition to an Open Access format in 2013, it has become an invaluable resource for researchers and professionals seeking to disseminate and access high-quality findings. With its ISSN 2307-9266 and E-ISSN 2413-2241, this journal covers a broad range of topics, providing a platform for the latest developments in pharmaceutical sciences. It is noteworthy that, as of 2023, Farmatsiya i Farmakologiya is categorized in various quartiles, with its Q2 ranking in Pharmacology (nursing) and Q3 in Pharmacy indicating its growing impact and relevance within its field. With the journal's commitment to fostering innovation and collaboration in pharmacy and pharmacology research, it serves as an essential hub for academics, practitioners, and students aiming to contribute to and stay informed about the dynamic landscape of this critical discipline.

The Egyptian Pharmaceutical Journal, published by Wolters Kluwer Medknow Publications, stands as a vital resource for researchers and practitioners in the fields of pharmaceutical sciences and biotechnology. With an ISSN of 1687-4315 and E-ISSN of 2090-9853, this journal disseminates high-quality, peer-reviewed research that spans a wide array of topics including pharmacology, toxicology, and biochemistry. Despite its emerging status, as reflected in its current Q4 and Q3 quartile rankings across various categories, the journal plays a significant role in contributing to the academic dialogue and promoting innovative findings within the scientific community. Operating from India, the journal is committed to open access principles, ensuring that cutting-edge research is readily available to a global audience. As the journal continues to evolve from its 2019 to 2024 convergence period, it aims to further enhance its impact factor and broaden its scope in the interdisciplinary domains of pharmaceutical sciences. Whether you are a student exploring new frontiers or a seasoned researcher aiming to publish your findings, The Egyptian Pharmaceutical Journal remains a dynamic platform for advancement in your field.

Pharmacy Practice-Granada is an esteemed academic journal dedicated to advancing the field of pharmacy and pharmaceutical sciences. Published by CENTRO INVESTIGACIONES & PUBLICACIONES FARMACEUTICAS, this journal has been a pioneer in Open Access publishing since 2006, allowing researchers worldwide to disseminate their findings without barriers. Operating out of Spain, it provides a platform for innovative research and critical discourse in pharmaceutical practice and education. As of 2023, the journal is ranked in the Q2 category for Pharmaceutical Science and holds a prestigious Q1 ranking in Pharmacy, reflecting its impact and contribution within the academic community. With a strong Scopus ranking, positioned as #6 out of 45 in Health Professions – Pharmacy and a percentile of 87%, the journal serves as a vital resource for practitioners, researchers, and students alike who are committed to enhancing health outcomes through pharmacy. With a commitment to high-quality research, Pharmacy Practice-Granada aims to support knowledge exchange and foster collaborative efforts, ultimately shaping the future of pharmaceutical care.

Tropical Journal of Pharmaceutical Research is an esteemed open-access platform dedicated to advancing the field of pharmaceutical sciences, published by the Pharmacotherapy Group in Nigeria. With an ISSN of 1596-5996 and open access established since 2002, this journal serves as a critical resource for researchers, professionals, and students seeking to disseminate and access high-quality research in both pharmaceutical science and pharmacology. Despite its ranking in the third quartile (Q3) for Pharmaceutical Science and the fourth quartile (Q4) in Pharmacology as of 2023, the journal continues to stand out with its commitment to fostering significant dialogue and innovation in the scientific community. Anchored at the University of Benin, Faculty of Pharmacy, the journal invites contributions that explore novel pharmaceutical research, clinical applications, and drug development, playing a vital role in addressing health challenges that are particularly relevant to tropical regions. Researchers can look forward to publishing their findings in a journal that not only promotes the sharing of knowledge but also enhances the scientific discourse within a rapidly evolving field.

The Brazilian Journal of Pharmaceutical Sciences is a prestigious and peer-reviewed journal dedicated to disseminating significant research across the fields of Pharmacology, Toxicology, and Pharmaceutics. Published by UNIV SAO PAULO, CONJUNTO QUIMICAS, this journal has been an Open Access platform since 2009, making it accessible to a global audience, fostering collaboration and knowledge sharing among researchers and professionals. With an ISSN of 1984-8250 and an E-ISSN of 2175-9790, it holds a respectable Q3 ranking in these fields for 2023, indicating its contribution to the scientific community's understanding and advancement of pharmaceutical sciences. As it converges from 2009 to 2024, the journal continues to address emerging trends and critical topics in drug development, safety, and efficacy, positioning itself as an essential resource for students, researchers, and practitioners seeking to contribute to and stay informed about advancements in pharmacological research. With its publication address in São Paulo, Brazil, the journal serves as a key outlet for Brazilian and international scholars alike.

The Journal of Pharmacy and Bioallied Sciences is a premier open access publication that has been contributing to the fields of Pharmacy, Bioengineering, and Biochemistry since its establishment in India, under the esteemed Wolters Kluwer Medknow Publications. With the ISSN 0976-4879 and E-ISSN 0975-7406, this journal provides a platform for high-quality research articles, reviews, and clinical studies aimed at advancing knowledge and practice in the pharmaceutical and allied sciences. As a reflection of its academic stature, the journal holds a respectable categorization within the third and fourth quartiles in pertinent fields according to the latest metrics, with rankings that place it among prominent emerging research in pharmacology and biochemistry. Researchers and professionals are encouraged to access a wealth of knowledge freely, as the journal has been open access since 2010. The journal not only aims to foster innovative research but also strives to bridge the gap between pharmaceutical sciences and real-world applications, making it an essential resource for students, academics, and industry experts alike.

Acta Pharmaceutica Sinica B is a prestigious open access journal that has been setting the standard in the field of pharmacology, toxicology, and pharmaceutics since its establishment in 2011. Published by the Institute of Materia Medica, Chinese Academy of Medical Sciences, the journal serves as a vital platform for researchers, professionals, and students seeking to disseminate innovative findings in drug development, pharmaceutical sciences, and therapeutic applications. With an impressive impact factor reflecting its high academic quality, Acta Pharmaceutica Sinica B has achieved Q1 status in the category of Pharmacology, Toxicology and Pharmaceutics as of 2023, ranking #1 out of 80 journals in General Pharmacology. This journal not only focuses on the latest advancements in drug research and formulation but also emphasizes interdisciplinary approaches, fostering collaborations that span various scientific domains. The accessible nature of the journal, combined with its rigorous peer-review process, ensures that crucial insights and breakthroughs reach a global audience swiftly and effectively. For those looking to stay at the forefront of pharmaceutical research, Acta Pharmaceutica Sinica B is an indispensable resource.

Indian Journal of Pharmaceutical Education and Research, published by the Association of Pharmaceutical Teachers of India, is a pivotal platform for scholarly discussion in the field of pharmacology, toxicology, and pharmaceutics. ISSN 0019-5464, this esteemed journal aims to foster the exchange of innovative research, clinical advancements, and educational practices within the pharmaceutical sciences community. As a Q3-ranked journal in its category as of 2023, it reflects a commitment to upholding the standards of academic excellence and contributes significantly to the ongoing development of pharmaceutical education. The journal is a valuable resource for researchers, professionals, and students, with content spanning various key areas including drug formulation, safety, and the latest trends in pharmaceutical education. By providing open access to its research and reviews, the journal ensures that vital information is disseminated widely, promoting collaboration and learning among stakeholders in the pharmaceutical sector. Based in Bangalore, India, the journal has been instrumental in highlighting regional research while fostering a global dialogue in pharmaceutical sciences. As it continues its journey from 2008 to 2024, it remains dedicated to impacting the field through rigorous peer-reviewed content and engaging with contemporary challenges in healthcare and education.

Advances in Pharmacology and Pharmacy is a pioneering journal devoted to the dissemination of cutting-edge research in the fields of pharmacology and pharmaceutical sciences. Published by Horizon Research Publishing, this peer-reviewed journal boasts a commitment to advancing knowledge and innovation, making it an essential resource for researchers, industry professionals, and students alike. With an ISSN of 2332-0036 and an E-ISSN of 2332-0044, it provides a platform for high-quality research articles that explore new therapeutic approaches, drug development strategies, and the regulatory aspects of pharmaceutical science. Although currently lacking a formal impact factor, the journal's emphasis on open access ensures that articles are widely available, promoting the sharing of valuable insights and collaborative efforts in the scientific community. Located at 506 N Garfield Ave, Ste 210, Alhambra, CA 91801, the journal welcomes contributions from diverse areas within pharmacology and pharmacy, reinforcing its significance as a vital resource in the ever-evolving landscape of pharmaceutical research.